Apogee Therapeutics Inc Annual Shareholders Meeting Transcript
Welcome to the Apogee Therapeutics 2026 Annual Meeting of Shareholders. My name is Mark McKenna, Chairman of Apogee's Board of Directors in today's meeting.
Thank you all for joining us today. Let me begin by introducing your Board of Directors: Dr. Michael Henderson, our Chief Executive Officer; Dr. Lisa Bollinger; Jennifer Fox; William Jones, Jr.; Tomas Kiselak; and Nimish Shah.
I would also like to introduce other members of the management team who are joining us today: Jane Henderson, Chief Financial Officer; Dr. Carl Dambkowski, Chief Medical Officer; Matt Batters, Chief Legal Officer and Corporate Secretary. Representatives of our independent registered public accounting firm, Ernst & Young, are also joining us today.
Matt Batters will serve as Secretary of the meeting, and a representative of the Carideo Group has been appointed Inspector of Elections to examine and count proxies and votes for this meeting.
This meeting will be conducted in accordance with the meeting and rules of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
